Asterias Biotherapeutics, Inc.: key financial figures for fiscal year 2017 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2017)
- $4.0M
- Net Income/Loss (FY2017)
- -$28.4M
- Total Assets (FY2017)
- $43.1M
- Total Equity (FY2017)
- $33.5M
- Cash Flows from Operating Activities (FY2017)
- -$24.4M
Source: Asterias Biotherapeutics, Inc. 10-K filing (FY2017). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
